Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
Clinical trial NCT00362726 · COMPLETED
Trial details
- NCT number
- NCT00362726
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2006-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.